retatrutide clinical data retatrutide is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ Insurance coverage just changed Metabolic Research Size:60

retatrutide clinical data retatrutide is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ Insurance coverage just changed Metabolic Research Size:60

Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss. https://www.abc27.com/national/glp-1-insurance-change-impacts-millions-of-americans-what-to-know-how-to-tell ...

In contrast to older therapies, GLP-1 agents also slow gastric emptying, which further stabilizes glucose levels after meals

Metabolic Research

Size:60

The post lists pre-existing medullary thyroid cancer, a personal or family history of multiple endocrine neoplasia type 2, uncontrolled type 1 diabetes, severe renal impairment with an eGFR under 30, and pregnancy or lactation